Cinctive Capital Management LP Acquires 55,756 Shares of Avantor, Inc. (NYSE:AVTR)

Cinctive Capital Management LP raised its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 53.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 159,242 shares of the company's stock after buying an additional 55,756 shares during the quarter. Cinctive Capital Management LP's holdings in Avantor were worth $4,120,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its stake in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock valued at $25,000 after purchasing an additional 1,102 shares during the period. Blue Trust Inc. lifted its holdings in shares of Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock worth $31,000 after purchasing an additional 1,391 shares during the last quarter. UMB Bank n.a. bought a new position in Avantor during the 3rd quarter worth $49,000. Nisa Investment Advisors LLC grew its position in shares of Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock worth $53,000 after acquiring an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock valued at $70,000 after purchasing an additional 1,285 shares during the period. Institutional investors and hedge funds own 95.08% of the company's stock.

Analysts Set New Price Targets

AVTR has been the subject of several recent research reports. Wells Fargo & Company cut their price objective on Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Royal Bank of Canada restated an "outperform" rating and set a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Barclays cut their target price on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Friday, October 25th. UBS Group lowered their price objective on Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a report on Tuesday, October 8th. Finally, Robert W. Baird reduced their target price on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a report on Monday, October 28th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. This trade represents a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company's stock.

Avantor Trading Up 0.2 %

Shares of AVTR stock traded up $0.04 during trading hours on Tuesday, hitting $21.14. The company had a trading volume of 2,029,552 shares, compared to its average volume of 6,465,121. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The company's fifty day moving average is $23.28 and its 200 day moving average is $23.71. The stock has a market capitalization of $14.39 billion, a PE ratio of 45.85, a price-to-earnings-growth ratio of 2.55 and a beta of 1.29.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.